Donepezil

Name /bks_53161_deglins_md_disk/donepezil 02/12/2014 01:31PM Plate # 0-Composite pg 1 # 1
1 NSAIDs; History of seizures; History of asthma or obstructive pulmonary disease; OB,

Lactation, Pedi: Safety not established; assumed to be secreted in breast milk. Dis-
PDF Page #1
donepezil (doe-nep-i-zill) continue drug or bottle-feed.
Aricept, Aricept ODT Adverse Reactions/Side Effects
Classification CNS: headache, abnormal dreams, depression, dizziness, drowsiness, fatigue, in-
Therapeutic: anti-Alzheimer’s agents somnia, syncope, sedation (unusual). CV: atrial fibrillation, hypertension, hypoten-
Pharmacologic: cholinergics (cholinesterase inhibitors) sion, vasodilation. GI: diarrhea, nausea, anorexia, vomiting, weight gain (unusual).
Pregnancy Category C GU: frequent urination. Derm: ecchymoses. Metab: hot flashes, weight loss. MS:
arthritis, muscle cramps.
Indications Interactions
Mild, moderate, or severe dementia/neurocognitive disorder associated with Alzhei- Drug-Drug: Exaggerates muscle relaxation from succinylcholine. Interferes with
mer’s disease. the action of anticholinergics.qcholinergic effects of bethanechol. Mayqrisk of
GI bleeding from NSAIDs. Quinidine and ketoconazolepmetabolism of donepe-
Action zil. Rifampin, carbamazepine, dexamethasone, phenobarbital, and phenyt-
Inhibits acetylcholinesterase thus improving cholinergic function by making more
oin induce the enzymes that metabolize donepezil and maypits effects.
acetylcholine available. Therapeutic Effects: May temporarily lessen some of the
dementia associated with Alzheimer’s disease. Enhances cognition. Does not cure the Drug-Natural Products: Jimson weed and scopolia may antagonize choliner-
disease. gic effects.
Pharmacokinetics Route/Dosage
Absorption: Well absorbed after oral administration. Mild to Moderate Alzheimer’s Disease
Distribution: Unknown. PO (Adults): 5 mg once daily; after 4– 6 wk mayqto 10 mg once daily (dose should
Protein Binding: 96%. not exceed 5 mg/day in frail, elderly females).
Metabolism and Excretion: Partially metabolized by the liver (CYP2D6 and Severe Alzheimer’s Disease
CYP3A4 enyzmes) and partially excreted by kidneys (17% unchanged). Two metabo- PO (Adults): 5 mg once daily; mayqto 10 mg once daily after 4– 6 wk; after 3 mo,
lites are pharmacologically active. may thenqto 23 mg once daily.
Half-life: 70 hr.
TIME/ACTION PROFILE (improvement in symptoms)
NURSING IMPLICATIONS
ROUTE ONSET PEAK DURATION
Assessment
● Assess cognitive function (memory, attention, reasoning, language, ability to per-
PO unknown several wk 6 wk† form simple tasks) periodically during therapy.
†Return to baseline after discontinuation ● Monitor heart rate periodically during therapy. May cause bradycardia.
Contraindications/Precautions Potential Nursing Diagnoses
Contraindicated in: Hypersensitivity to donepezil or piperidine derivatives. Disturbed thought process (Indications)
Use Cautiously in: Underlying cardiac disease, especially sick sinus syndrome or Impaired environmental interpretation syndrome (Indications)
supraventricular conduction defects; History of ulcer disease or currently taking Risk for injury (Indications)
⫽ Canadian drug name. ⫽ Genetic Implication. CAPITALS indicate life-threatening, underlines indicate most frequent. Strikethrough ⫽ Discontinued.
Name /bks_53161_deglins_md_disk/donepezil 02/12/2014 01:31PM Plate # 0-Composite pg 2 # 2
2
Implementation PDF Page #2
● Do not confuse Aricept with Aciphex or Azilect.
● PO: Administer in the evening just before going to bed. May be taken without re-
gard to food.
● Oral disintegrating tablets should be allowed to dissolve on tongue; follow with
water.
● Swallow 23 mg tablet whole. Do not split, crush or chew; may increase rate of ab-
sorption.
Patient/Family Teaching
● Emphasize the importance of taking donepezil daily, as directed. Missed doses
should be skipped and regular schedule returned to the following day. Do not take
more than prescribed; higher doses do not increase effects but may increase side
effects.
● Inform patient/family that it may take weeks before improvement in baseline be-
havior is observed.
● Caution patient and caregiver that donepezil may cause dizziness.
● Advise patient and caregiver to notify health care professional if nausea, vomiting,
diarrhea, or changes in color of stool occur or if new symptoms occur or previ-
ously noted symptoms increase in severity.
● Instruct patient to notify health care professional of all Rx or OTC medications, vi-
tamins, or herbal products being taken and to consult health care professional be-
fore taking other Rx, OTC, or herbal products.
● Advise patient and caregiver to notify health care professional of medication regi-
men before treatment or surgery.
● Emphasize the importance of follow-up exams to monitor progress.
Evaluation/Desired Outcomes
● Improvement in cognitive function (memory, attention, reasoning, language, abil-
ity to perform simple tasks) in patients with Alzheimer’s disease.
Why was this drug prescribed for your patient?
䉷 2015 F.A. Davis Company

Donepezil

Uploaded by

Copyright:

Available Formats

Donepezil

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Donepezil

Uploaded by

Copyright:

Available Formats

Name /bks_53161_deglins_md_disk/donepezil 02/12/2014 01:31PM Plate # 0-Composite pg 1 # 1

1 NSAIDs; History of seizures; History of asthma or obstructive pulmonary disease; OB,

䉷 2015 F.A. Davis Company

You might also like